Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective We examine weight gain and metabolic consequences of risperidone monotherapy in children with autism spectrum disorder (ASD). Method This was a 24-week, multisite, randomized trial of risperidone only versus risperidone plus parent training in 124 children (mean age 6.9 ± 2.35 years; 105 boys, 19 girls) with ASD and serious behavioral problems. We monitored height, weight, waist circumference, and adverse effects during the trial. Fasting blood samples were obtained pretreatment and at Week 16. Results In 97 patients with a mean of 22.9 ± 2.8 weeks risperidone exposure, there was a 5.4 ± 3.4 kg weight gain over 24 weeks (p < .0001); waist circumference increased from 60.7 ± 10.4 cm to 66.8 ± 11.3 cm (p <. 0001). At baseline 60.8% (59 of 97) patients were classified as having normal weight; by Week 24, only 29.4% (25 of 85) remained in that group. Growth curve analysis showed a significant change in body mass index (BMI) z-scores from pretreatment to Week 24 (p<.0001). This effect was significantly greater for patients with reported increased appetite in the first 8 weeks. From pretreatment to Week 16, there were significant increases in glucose (p=.02), hemoglobin A1c (p=.01), insulin (p <.0001), homeostatic model assessment–insulin resistance (HOMA-IR; p< .001), alanine aminotransferase (p=.01), and leptin (p < .0001). Adiponectin declined (p =.003). At baseline, 7 patients met conventional criteria for metabolic syndrome; by Week 16, 12 additional patients were so classified. Conclusion Rapid weight gain with risperidone treatment may promote the cascade of biochemical indices associated with insulin resistance and metabolic syndrome. Appetite, weight, waist circumference, liver function tests, blood lipids, and glucose warrant monitoring. Clinical trial registration information Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders; http://clinicaltrials.gov/; NCT00080145
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome in children and adolescents ? an IDF consensus report
Zimmet, P., Alberti, K. G. M., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., et al. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00271.x · Cited by 2,013
Self-citationPrevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Self-citationRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Self-citationLipid screening and cardiovascular health in childhood
Daniels, S. R., Greer, F. R., & and the Committee on Nutrition (2008) · Pediatrics · doi:10.1542/peds.2008-1349 · Cited by 1,178
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613
Bearss, K., Johnson, C., Smith, T., Lecavalier, L., Swiezy, N., Aman, M., McAdam, D. B., Butter, E., Stillitano, C., Minshawi, N., et al. (2015) · JAMA · doi:10.1001/jama.2015.3150 · Cited by 454
Self-citationInsulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Aman, M. G., Mcdougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., Stigler, K. A., Bearss, K., Butter, E., Swiezy, N. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181bfd669 · Cited by 371
Self-citation
Cited by
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Aran, A., Harel, M., Cassuto, H., Polyansky, L., Schnapp, A., Wattad, N., Shmueli, D., Golan, D., & Castellanos, F. X. (2021) · Molecular Autism · doi:10.1186/s13229-021-00420-2 · Cited by 223
“Food and Drug Administration (FDA) to treat comorbid irritability [2] but these medications often cause obesity and metabolic syndrome [2, 39].”
BackgroundPostorino, V., Sharp, W. G., McCracken, C. E., Bearss, K., Burrell, T. L., Evans, A. N., & Scahill, L. (2017) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-017-0237-2 · Cited by 210
“medication has well-established risks (Scahill et al. 2016).”
BackgroundSelf-citationKahathuduwa, C. N., West, B. D., Blume, J., Dharavath, N., Moustaid‐Moussa, N., & Mastergeorge, A. (2019) · Obesity Reviews · doi:10.1111/obr.12933 · Cited by 162
Correlates of Feeding Difficulties Among Children with Autism Spectrum Disorder: A Systematic Review
Page, S. D., Souders, M. C., Kral, T. V. E., Chao, A. M., & Pinto-Martin, J. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-04947-4 · Cited by 114
Politte, L. C., Scahill, L., Figueroa, J., McCracken, J. T., King, B., & McDougle, C. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0039-3 · Cited by 90
“However, concern for weight gain and related metabolic adverse effects limits the use of risperidone to children with serious behavioral problems [41].”
BackgroundSelf-citation
Metadata
- Authors
- Scahill, L., Jeon, S., Boorin, S. J., McDougle, C. J., Aman, M. G., Dziura, J., McCracken, J. T., Caprio, S., Arnold, L. E., Nicol, G., Deng, Y., Challa, S. A., & Vitiello, B.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 55
- Issue
- 5
- Pages
- 415-423
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2293695912
- Cited by
- 85
- References
- 9
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.